140 related articles for article (PubMed ID: 2168143)
1. Inhibitory effects of atropine, protamine, and their combination on hepatitis A virus replication in PLC/PRF/5 cells.
Biziagos E; Crance JM; Passagot J; Deloince R
Antimicrob Agents Chemother; 1990 Jun; 34(6):1112-7. PubMed ID: 2168143
[TBL] [Abstract][Full Text] [Related]
2. Effect of antiviral substances on hepatitis A virus replication in vitro.
Biziagos E; Crance JM; Passagot J; Deloince R
J Med Virol; 1987 May; 22(1):57-66. PubMed ID: 3035080
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of carrageenan on hepatitis A virus replication in cell culture.
Girond S; Crance JM; Van Cuyck-Gandre H; Renaudet J; Deloince R
Res Virol; 1991; 142(4):261-70. PubMed ID: 1665574
[TBL] [Abstract][Full Text] [Related]
4. Effect of glutaraldehyde on the antigenicity and infectivity of hepatitis A virus.
Passagot J; Crance JM; Biziagos E; Laveran H; Agbalika F; Deloince R
J Virol Methods; 1987 May; 16(1-2):21-8. PubMed ID: 3038939
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of recombinant interferon-alpha on hepatitis A virus replication in human liver cells.
Crance JM; Lévêque F; Chousterman S; Jouan A; Trépo C; Deloince R
Antiviral Res; 1995 Sep; 28(1):69-80. PubMed ID: 8585761
[TBL] [Abstract][Full Text] [Related]
6. Failure of guanidine and 2-(alpha-hydroxybenzyl)benzimidazole to inhibit replication of hepatitis A virus in vitro.
Siegl G; Eggers HJ
J Gen Virol; 1982 Jul; 61 (Pt l)():111-4. PubMed ID: 6288846
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hepatitis A virus replication in vitro by antiviral compounds.
Crance JM; Biziagos E; Passagot J; van Cuyck-Gandré H; Deloince R
J Med Virol; 1990 Jun; 31(2):155-60. PubMed ID: 2167349
[TBL] [Abstract][Full Text] [Related]
8. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro.
Crance JM; Lévêque F; Biziagos E; van Cuyck-Gandré H; Jouan A; Deloince R
Antiviral Res; 1994 Jan; 23(1):63-76. PubMed ID: 8141593
[TBL] [Abstract][Full Text] [Related]
9. [Release of hepatitis A virus into the culture medium, during its replication in PLC/PRF/5 cells].
Crance JM; Deloince R; Lechevallier C; Crevat D; Laveran H; Fontanges R
C R Seances Acad Sci III; 1983; 297(3):111-4. PubMed ID: 6318925
[TBL] [Abstract][Full Text] [Related]
10. [Antiviral effect of recombinant interferon-alpha on hepatitis A virus replication in human liver cells].
Crance JM; Deloince R; Leveque F; Jouan A; Trépo C
C R Acad Sci III; 1994 Jan; 317(1):94-7. PubMed ID: 7987698
[TBL] [Abstract][Full Text] [Related]
11. Methisoprinol-effect on the replication cycle of human hepatitis A virus.
Divizia M; Venuti A; Degener AM; Perez-Bercoff R; Panà A
Microbiologica; 1992 Oct; 15(4):323-8. PubMed ID: 1279362
[TBL] [Abstract][Full Text] [Related]
12. TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.
Das A; Hirai-Yuki A; González-López O; Rhein B; Moller-Tank S; Brouillette R; Hensley L; Misumi I; Lovell W; Cullen JM; Whitmire JK; Maury W; Lemon SM
mBio; 2017 Sep; 8(5):. PubMed ID: 28874468
[TBL] [Abstract][Full Text] [Related]
13. Propagation and assay of hepatitis A virus in vitro.
Siegl G; deChastonay J; Kronauer G
J Virol Methods; 1984 Aug; 9(1):53-67. PubMed ID: 6094609
[TBL] [Abstract][Full Text] [Related]
14. [Adaptation to the cell line PLC/PRF/5 of hepatitis A virus released in the cell culture medium].
Crance JM; Passagot J; Verwaerde N; Biziagos E; Gandré H; Deloince R
C R Acad Sci III; 1985; 301(7):361-3. PubMed ID: 2998570
[TBL] [Abstract][Full Text] [Related]
15. Effect of isoflavans and isoflavenes on the infection of Frp/3 cells by hepatitis A virus.
Superti F; Seganti L; Orsi N; Divizia M; Gabrieli R; Panà A; Stein ML
Antiviral Res; 1989; 11(5-6):247-54. PubMed ID: 2552913
[TBL] [Abstract][Full Text] [Related]
16. Effect of cellular function inhibitors on the infection of Frp/3 cells by hepatitis A virus.
Superti F; Seganti L; Orsi N; Divizia M; Gabrieli R; Panà A
Med Microbiol Immunol; 1989; 178(1):29-36. PubMed ID: 2535886
[TBL] [Abstract][Full Text] [Related]
17. Continuous production of hepatitis A virus in PLC/PRF/5 cell cultures: use of antigen for serology.
Crance JM; Passagot J; Biziagos E; Deloince R
J Virol Methods; 1987 Nov; 18(2-3):193-203. PubMed ID: 2828401
[TBL] [Abstract][Full Text] [Related]
18. Rapid completion of the replication cycle of hepatitis A virus subsequent to reversal of guanidine inhibition.
Cho MW; Ehrenfeld E
Virology; 1991 Feb; 180(2):770-80. PubMed ID: 1846497
[TBL] [Abstract][Full Text] [Related]
19. Suppression of hepatitis B virus replication mediated by hepatitis A-induced cytokine production.
van Nunen AB; Pontesilli O; Uytdehaag F; Osterhaus AD; de Man RA
Liver; 2001 Feb; 21(1):45-9. PubMed ID: 11169072
[TBL] [Abstract][Full Text] [Related]
20. [The reproduction of the hepatitis A virus in cell cultures].
Farashian VR; Bychenko AB; Artemov EK; Kuzaeva IA
Vopr Virusol; 1991; 36(3):209-12. PubMed ID: 1654008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
